Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cyclerion Therapeutics, Inc. - Common Stock (NQ:CYCN)

3.360 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	3.360
Bid (Size)	3.060 (300)
Ask (Size)	3.510 (100)
Prev. Close	3.360
Today's Range	3.360 - 3.360
52wk Range	7.186 - 59.36
Shares Outstanding	43,524,894
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)

April 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders

April 07, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Performance

52-Week Range 94.3% below 52-week high

3.360

7.1952W Low 59.3652W High

Cyclerion Therapeutics, Inc. - Common Stock (CYCN) traded between $7.19 and $59.36 over the past 52 weeks and last traded at $3.36, 94.3% below its 52-week high.

Past 12 Months

N/A

-87.4%

-83.4%

-64.2%

-79.1%

3M -$23.38

6M -$16.87

YTD -$6.02

1Y -$12.74

CYCN was -79.1% over the past year, -83.4% over six months, -64.2% year to date.

12 Months vs Market

CYCN

-79.1%

DIA

+12.4%

SPY

+17.3%

QQQ

+23.9%

IWM

+13.8%

Over the past 12 months CYCN returned -79.1% versus DIA (Dow) +12.4%, SPY (S&P 500) +17.3%, QQQ (Nasdaq 100) +23.9% and IWM (Russell 2000) +13.8%.

Volume & Liquidity

6.5K

8.8K

YTD

318.2K

253.4K

CYCN's 3-month average daily volume is 6.5K.

More News

Monday's session: top gainers and losers ↗

April 06, 2026

Via Chartmill

Monday's session: gap up and gap down stocks ↗

April 06, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

April 06, 2026

Via Chartmill

Halper Sadeh LLC is Investigating Whether UNF, CYCN, NSA, ULYX are Obtaining Fair Deals for their Shareholders

April 03, 2026

From Halper Sadeh LLC

Via GlobeNewswire

April 02, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Unusual volume stocks in Thursday's session ↗

April 02, 2026

Via Chartmill

CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

April 02, 2026

From Halper Sadeh LLC

Via Business Wire

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement

April 01, 2026

From Korsana Biosciences, Inc. and Cyclerion Therapeutics, Inc.

Via Business Wire

Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

February 17, 2026

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

January 07, 2026

Via Chartmill

Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗

January 06, 2026

Via Chartmill

Curious about the most active stocks on Tuesday? ↗

January 06, 2026

Via Chartmill

FOCUSfactor® Beverage Emerges as a Growth Catalyst for Synergy CHC Corp. (NASDAQ: SNYR) – Alongside CYCN, ALMS, EVTV, RDZN See Why

January 06, 2026

Via AB Newswire

Unusual volume stocks are being observed in Tuesday's session. ↗

January 06, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

January 06, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

January 06, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 06, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

January 05, 2026

Via Chartmill

Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression

January 05, 2026

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

Wednesday's after hours session: top gainers and losers ↗

November 12, 2025

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

November 11, 2025

Via Chartmill

Get insights into the top gainers and losers of Tuesday's pre-market session. ↗

November 11, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 11, 2025

Via Benzinga

Frequently Asked Questions

Is Cyclerion Therapeutics, Inc. - Common Stock publicly traded?

Yes, Cyclerion Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Cyclerion Therapeutics, Inc. - Common Stock trade on?

Cyclerion Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cyclerion Therapeutics, Inc. - Common Stock?

The ticker symbol for Cyclerion Therapeutics, Inc. - Common Stock is CYCN on the Nasdaq Stock Market

What is the current price of Cyclerion Therapeutics, Inc. - Common Stock?

The current price of Cyclerion Therapeutics, Inc. - Common Stock is 3.360

When was Cyclerion Therapeutics, Inc. - Common Stock last traded?

The last trade of Cyclerion Therapeutics, Inc. - Common Stock was at 09/08/26 04:00 PM ET

What is the market capitalization of Cyclerion Therapeutics, Inc. - Common Stock?

The market capitalization of Cyclerion Therapeutics, Inc. - Common Stock is 146.24M

How many shares of Cyclerion Therapeutics, Inc. - Common Stock are outstanding?

Cyclerion Therapeutics, Inc. - Common Stock has 146M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.